Levofloxacino Viatris (Levofloxacin)

Levofloxacin exerts its antibacterial effect by inhibiting two essential bacterial enzymes: DNA gyrase (topoisomerase II) and topoisomerase IV. These enzymes are required for DNA replication, transcription, and chromosome segregation. By blocking their activity, levofloxacin prevents bacterial DNA from unwinding and replicating, leading to bacterial cell death and clearance of the infection.

The specific dose of Levofloxacino Viatris is determined by the prescribing clinician based on the infection being treated, the patient’s age, weight, renal function, and other clinical considerations. Dosage regimens can vary widely, so the prescriber sets the appropriate amount and schedule for each individual case.

Safety data for levofloxacin in pregnancy and lactation are limited, and the drug is generally classified as contraindicated or to be used only when the potential benefit outweighs the risk. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss alternatives with their healthcare provider before using this medication.

To request Levofloxacino Viatris, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will ask for trade or institutional credentials. The sales team then replies with pricing, availability, shipping details (including any cold‑chain requirements), and the necessary import documentation.

Levofloxacino Viatris belongs to the fluoroquinolone class, which offers broad‑spectrum activity against many Gram‑negative and Gram‑positive bacteria and provides convenient once‑daily oral dosing. Compared with macrolides or beta‑lactams, fluoroquinolones often have higher tissue penetration but carry distinct safety considerations such as tendon toxicity and QT prolongation. Choice of therapy depends on the pathogen, resistance patterns, and patient risk factors.

Levofloxacino Viatris should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in bathrooms or other humid environments. No refrigeration is required for this oral formulation.

Levofloxacino Viatris is taken orally, usually with a full glass of water. It can be taken with or without food, but antacids containing aluminum or magnesium should be spaced at least two hours apart to avoid reduced absorption. Swallow the tablet whole; do not crush or chew unless specifically instructed by a healthcare professional.

Serious adverse events linked to levofloxacin include tendon rupture (especially the Achilles tendon), QT interval prolongation leading to cardiac arrhythmias, severe Clostridioides difficile‑associated diarrhea, peripheral neuropathy, and life‑threatening allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience sudden tendon pain, palpitations, severe diarrhea, numbness, or signs of an allergic reaction.

Levofloxacino Viatris should be avoided in individuals with a known hypersensitivity to levofloxacin or any fluoroquinolone, those with a history of tendon disorders related to fluoroquinolone use, patients with myasthenia gravis, and anyone taking medications that significantly prolong the QT interval without careful monitoring. Clinicians must also consider renal impairment and adjust therapy accordingly.